Welcome to our dedicated page for Parker-Hannifin SEC filings (Ticker: PH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to locate the aerospace backlog, pension costs or acquisition details buried in Parker-Hannifin’s latest 300-page 10-K? Diversified industrial giants bundle multiple business lines and complex accounting notes, making it hard to spot what moves the stock.
Stock Titan’s AI turns every Parker-Hannifin SEC filing into plain-English insight—whether you need a one-minute brief or a deep dive. Our real-time feed covers every form as it hits EDGAR, from a routine 10-Q quarterly earnings report to an unexpected 8-K material event. You’ll see:
- Parker-Hannifin quarterly earnings report 10-Q filing distilled into segment margin trends
- Parker-Hannifin annual report 10-K simplified with AI-highlighted cash-flow drivers
- Parker-Hannifin Form 4 insider transactions real-time, including executive stock transactions Form 4
- Parker-Hannifin proxy statement executive compensation decoded for pay-for-performance links
- Parker-Hannifin 8-K material events explained within minutes
Need a quick answer? Ask naturally—“understanding Parker-Hannifin SEC documents with AI� or “Parker-Hannifin earnings report filing analysis”—and our platform surfaces the section, table or footnote you’re after. Investors monitor Parker-Hannifin insider trading Form 4 transactions ahead of contract announcements, compare segment sales quarter-over-quarter, and track goodwill impairment risks after acquisitions—all without opening a PDF.
Fire up Stock Titan’s AI-powered summaries, set custom alerts, and turn complex motion-control disclosures into actionable knowledge in seconds.
Parker-Hannifin filed a Form 144 reporting a proposed sale of 575 shares of common stock through UBS Financial Services, with an approximate aggregate market value of $421,511. The shares were acquired on 04/24/2025 as a restricted stock unit (RSU) vest and the proposed sale date listed is 08/08/2025. The filing shows 127,778,004 shares outstanding, so the block offered represents a very small portion of the company’s total equity. The filer also indicates no securities sold during the past three months and includes the customary Form 144 representation about lack of undisclosed material information.
Parker-Hannifin Form 144 notifies a proposed sale of 360 shares of common stock, with an aggregate market value of $261,000. The shares are to be sold on the NYSE through UBS Financial Services with an approximate sale date of 08/08/2025. The filing shows the shares were acquired on 08/08/2025 by a SAR exercise from Parker Hannifin and that payment was made by wire.
The form states there were no securities sold in the past three months for the account and includes the standard seller representation that they do not possess undisclosed material adverse information. Several administrative identification fields in the provided content (for example, filer CIK and person name) are blank in the excerpt supplied.
Parker-Hannifin Corporation submitted a Form 144 reporting a proposed sale of 588 shares of common stock through UBS on the NYSE, with an aggregate market value of $429,342 and 127,778,004 shares outstanding. The securities were acquired via a SAR exercise and paid by wire on 08/08/2025, and the filer reports no other sales in the past three months.
This notice is a routine insider sale disclosure of a single, small transaction. The quantity reported is a very small portion of the company’s outstanding stock, and the filing primarily serves to document the planned sale and the method of acquisition and payment.
Parker-Hannifin Corporation (PH) submitted a Rule 144 notice for a proposed sale of 2,257 common shares that were acquired as a stock award from the issuer on 04/24/2025. The form lists the intended broker as Kestra and an approximate sale date of 08/08/2025; the aggregate market value is stated as $1,660,000 and the number of shares outstanding is shown as 128,410,000. The nature of payment is identified as compensation.
The filing indicates no securities sold in the past three months. Several filer and contact fields in the provided text (including the filer CIK and the name of the person for whose account the securities are to be sold) are not populated in the content provided, so those identifying and contact details are not available here.
What happened: A Form 144 was filed relating to Parker‑Hannifin (PH) reporting a proposed sale of 278 common shares with an aggregate market value of $204,000.
Why it matters: The shares were acquired as a stock award on 08/26/2022 and the planned sale date is 08/08/2025 on the NYSE. The filer reports no sales in the past three months and certifies they do not have undisclosed material information. This filing is a routine insider sale notice and provides transparency about an intended sale of a small number of shares.
Form: 144 notice filed for Parker-Hannifin Corporation (PH) proposing sale of 1,133 common shares with an aggregate market value of $801,000.00.
Acquisition details: Shares were acquired on 04/24/2025 as a stock award from the issuer and payment is listed as compensation. The filing names broker Kestra (5707 Southwest Pkwy, Bldg 2, STE 400, Austin, TX 78735) and lists the intended exchange as NYSE.
Sale timing and history: Approximate date of sale is 08/08/2025. The filer reports no securities sold in the past 3 months for the account.
Filing: Parker-Hannifin Corporation (PH) Form 144 (LIVE) reporting a proposed sale under Rule 144.
Transaction details: 2,257 common shares to be sold through broker Kestra (address shown) on 08/08/2025 on the NYSE. Aggregate market value reported as $1,660,023.00 and shares outstanding listed as 128,410,000. The securities were acquired as a stock award on 04/24/2025; payment/consideration listed as compensation.
Other: The filer reports Nothing to Report for securities sold in the past three months. Remarks include the attestation about absence of undisclosed material adverse information and a signature notice.
Form 144 filed for Parker-Hannifin Corporation (PH) reporting a proposed sale of common stock by a person who acquired the shares as a stock award.
Key details:
- Shares to be sold: 4,361
- Aggregate market value: $3,140,000.00
- Shares outstanding (reported): 128,410,000
- Acquired: 04/24/2025 as a stock award (payment/compensation dated 04/24/2025)
- Approximate sale date: 08/08/2025 via broker Kestra (address provided) on the NYSE
- Securities sold in past 3 months: Nothing to Report
Form 144 filed for Parker-Hannifin Corporation (PH) reporting a proposed sale of 995 common shares through broker Kestra on the NYSE with an approximate sale date of 08/08/2025. The filing lists an aggregate market value of $702,000.00 and 128,410,000 shares outstanding.
All 995 shares were acquired as stock awards from the issuer: 660 shares on 02/24/2024 and 335 shares on 04/25/2024. The filer reports Nothing to Report for securities sold in the past three months and includes the standard representation regarding lack of undisclosed material adverse information.
Form 144 summary for Parker-Hannifin Corporation (PH). Proposed sale of 450 common shares with aggregate market value $330,000 on the NYSE.
Acquisition recorded as a stock award from the issuer on 04/24/2025, payment/award date same. Approximate sale date listed as 08/08/2025. Broker listed as Kestra, 5707 Southwest Pkwy bldg 2 STE 400, Austin TX 78735. Filing reports 128,410,000 shares outstanding and no securities sold in the past 3 months.
Filer represents they do not possess undisclosed material adverse information and acknowledges Rule 144 requirements.